Biological activity, membrane-targeting modification, and crystallization of soluble human decay accelerating factor expressed in E. coli.

Biological activity, membrane-targeting modification, and crystallization of soluble human decay accelerating factor expressed in E. coli.

Pokaži ostale verzije (1)

Decay-accelerating factor (DAF, CD55) is a glycophosphatidyl inositol-anchored glycoprotein that regulates the activity of C3 and C5 convertases. In addition to understanding the mechanism of complement inhibition by DAF through structural studies, there is also an interest in the possible therapeut...

Bibliografski detalji
Glavni autori:	White, J, Lukacik, P, Esser, D, Steward, M, Giddings, N, Bright, JR, Fritchley, S, Morgan, B, Lea, S, Smith, G, Smith, R
Format:	Journal article
Jezik:	English
Izdano:	2004

Slični predmeti

Biological activity, membrane-targeting modification, and crystallization of soluble human decay accelerating factor expressed in E. coli
od: White, J, i dr.
Izdano: (2004)

Complement regulation at the molecular level: the structure of decay-accelerating factor.
od: Lukacik, P, i dr.
Izdano: (2004)

Structural studies on decay accelerating factor and other complement regulators
od: Lukacik, P, i dr.
Izdano: (2001)

Molecular dissection of interactions between components of the alternative pathway of complement and decay accelerating factor (CD55).
od: Harris, C, i dr.
Izdano: (2005)

Molecular dissection of interactions between components of the alternative pathway of complement and decay accelerating factor (CD55)
od: Harris, C, i dr.
Izdano: (2005)

Surface plasmon resonance analysis of decay acceleration in the alternative pathway of complement
od: Harris, C, i dr.
Izdano: (2007)

Decay-accelerating factor must bind both components of the complement alternative pathway C3 convertase to mediate efficient decay.
od: Harris, C, i dr.
Izdano: (2007)

Decay-accelerating factor must bind both components of the complement alternative pathway C3 convertase to mediate efficient decay
od: Harris, C, i dr.
Izdano: (2007)

The crystal structure of rat complement receptor 1-related protein Y (CrrY) helps dissecting decay-acceleration and fI-cofactor activities
od: Roversi, P, i dr.
Izdano: (2008)

Expression of soluble and membrane proteins in <it>E. coli</it>
od: Georgiou George, i dr.
Izdano: (2006-10-01)

Structural and functional insights into the interaction of echoviruses and decay-accelerating factor.
od: Pettigrew, D, i dr.
Izdano: (2006)

Chemical Modification of Biomarkers through Accelerated Degradation: Implications for Ancient Plant Identification in Archaeo-Organic Residues
od: Barbara Huber, i dr.
Izdano: (2022-05-01)

SOME SOLUBLE MODELS FOR PERIODIC DECAY AND REVIVAL
od: Sukumar, C, i dr.
Izdano: (1984)

Protection against hyperacute rejection by transgenic expression of human decay accelerating factor after prolonged cold ischaemia in pig-to-primate renal xenotransplantation
od: Masroor, S, i dr.
Izdano: (2000)

High-resolution structures of bacterially expressed soluble human CD59
od: Leath, K, i dr.
Izdano: (2007)

High-resolution structures of bacterially expressed soluble human CD59.
od: Leath, K, i dr.
Izdano: (2007)

Modifications of the 5’ region of the CASPONTM tag’s mRNA further enhance soluble recombinant protein production in Escherichia coli
od: Christoph Köppl, i dr.
Izdano: (2024-03-01)

Increasing the Yield of Soluble Recombinant Protein Expressed in E. coli by Induction during Late Log Phase
od: Chad A. Galloway, i dr.
Izdano: (2003-03-01)

Accelerating Quantum Decay by Multiple Tunneling Barriers
od: Ermanno Pinotti, i dr.
Izdano: (2023-09-01)

Deterioration of Teak Wood in Accelerated Decay Test
od: Weslley Candido de Oliveira, i dr.
Izdano: (2019-05-01)

Decay acceleration of isomers by X-ray laser
od: A. Ya. Dzyublik
Izdano: (2010-12-01)

Purcell modification of Auger and interatomic Coulombic decay
od: Janine Franz, i dr.
Izdano: (2022-01-01)

Yield, solubility and conformational quality of soluble proteins are not simultaneously favored in recombinant Escherichia coli.
od: Martínez-Alonso, M, i dr.
Izdano: (2008)

Crystallization and preliminary X-ray diffraction analysis of three EGF domains of EMR2, a 7TM immune-system molecule.
od: Abbott, R, i dr.
Izdano: (2004)

Measurement of solubility curves for crystallization processes
od: Pee, Nai Yong.
Izdano: (2010)

Improving the Solubility of Aripiprazole by Multicomponent Crystallization
od: Qi Zhou, i dr.
Izdano: (2021-03-01)

Solubility and Crystallization Studies of Picolinic Acid
od: Diogo S. Baptista, i dr.
Izdano: (2023-02-01)

Impact of Crystal Habit on Solubility of Ticagrelor
od: Yan Ren, i dr.
Izdano: (2019-10-01)

Seawater degradation of PLA accelerated by water-soluble PVA
od: Huang Dan, i dr.
Izdano: (2020-12-01)

Soluble expression of recombinant proteins in the cytoplasm of <it>Escherichia coli</it>
od: Mortensen Kim, i dr.
Izdano: (2005-01-01)

Investigation of Crystallization and Salt Formation of Poorly Water-Soluble Telmisartan for Enhanced Solubility
od: Chulhun Park, i dr.
Izdano: (2019-02-01)

Tat peptide-mediated soluble expression of the membrane protein LSECtin-CRD in Escherichia coli.
od: Guofu Dong, i dr.
Izdano: (2013-01-01)

Crystal structure of a soluble CD28-Fab complex.
od: Evans, E, i dr.
Izdano: (2005)

Solubility and Crystallization of Piroxicam from Different Solvents in Evaporative and Cooling Crystallization
od: Iben Ostergaard, i dr.
Izdano: (2021-12-01)

EXACTLY SOLUBLE MODEL OF ATOM-PHONON COUPLING SHOWING PERIODIC DECAY AND REVIVAL
od: Buck, B, i dr.
Izdano: (1981)

Solubility of Carbamazepine Co-Crystals in Ethanolic Solution
od: Noor Ashila, Ramle, i dr.
Izdano: (2017)

Measurement of solubility and metastable curves for crystallization processes
od: Huang, Yahui.
Izdano: (2009)

Modulation of zircon solubility by crystal–melt dynamics
od: Szymanowski, Dawid, i dr.
Izdano: (2020)

Decay spectroscopy with Solenogam at the ANU Heavy Ion Accelerator Facility
od: Gerathy M. S. M., i dr.
Izdano: (2016-01-01)

Recent advances in recombinant production of soluble proteins in E. coli
od: Ario de Marco
Izdano: (2025-01-01)